I specialize in helping individuals with treatment-resistant depression (TRD) by offering Spravato (esketamine) therapy, an FDA-approved breakthrough treatment that provides new hope for those ...

Meaning, you have to go to a specialty treatment center and use the medication under the supervision of a licensed healthcare provider. After you take Spravato, you have to be observed for at ...

We are a REMS certified Spravato Treatment Center. Have you lost hope for improving your ongoing depression symptoms? We offer renewed hope for treatment-resistant depression with a new option.

The FDA has approved Johnson & Johnson’s (J&J) Spravato (esketamine) CIII nasal spray, marking the first monotherapy to be approved for adults with treatment-resistant depression (TRD). According to ...

According to J&J’s tally, that is one of 3,000 outpatient treatment centers in the U.S. that are certified to administer Spravato. Mattingly said patients can now choose to take Spravato with or ...

However, managing treatment-resistant depression often requires ... or oral tablets. “In our center, we’ve seen really incredible results with Spravato and ketamine in general,” Malina said. “We have ...

"Spravato is now available as a stand-alone treatment, meaning patients may ... for the first time since the 2017-18 flu season, the Centers for Disease Control and Prevention said.

The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of MDD in those ... at Providence Saint John’s Health Center in Santa Monica, CA, and ...

There’s also the chance it could be misused. Because of this, Spravato is only available at certified treatment centers where patients are closely monitored. You won’t be able to pick it up at ...

That is one of 3,000 outpatient treatment centers in the U.S. that are certified to administer Spravato, according to J&J's tally. Mattingly said patients can now choose to take Spravato with or ...